Fig. 2
From: Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment
Time course of the percentage plasma dd-cfDNA (in green) and serum creatinine concentration (in red), in relation to important clinical events. During the hospital admission, hemodialysis (HD; day 17) was initiated. Dd-cfDNA levels declined from 23 to 8.8% 3–5 h after kidney explantation. Dotted lines are added to connect separate measurements of creatinine and dd-cfDNA. Of note, no comparative serum creatinine measurement was performed at 7 days after the first administration of nivolumab